These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 23376346)

  • 1. Metalloprotein-based MRI probes.
    Matsumoto Y; Jasanoff A
    FEBS Lett; 2013 Apr; 587(8):1021-9. PubMed ID: 23376346
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Engineering Metalloprotein Functions in Designed and Native Scaffolds.
    Nastri F; D'Alonzo D; Leone L; Zambrano G; Pavone V; Lombardi A
    Trends Biochem Sci; 2019 Dec; 44(12):1022-1040. PubMed ID: 31307903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rational design of protein-based MRI contrast agents.
    Yang JJ; Yang J; Wei L; Zurkiya O; Yang W; Li S; Zou J; Zhou Y; Maniccia AL; Mao H; Zhao F; Malchow R; Zhao S; Johnson J; Hu X; Krogstad E; Liu ZR
    J Am Chem Soc; 2008 Jul; 130(29):9260-7. PubMed ID: 18576649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Magnetite-nanoparticle-encapsulated pH-responsive polymeric micelle as an MRI probe for detecting acidic pathologic areas.
    Gao GH; Im GH; Kim MS; Lee JW; Yang J; Jeon H; Lee JH; Lee DS
    Small; 2010 Jun; 6(11):1201-4. PubMed ID: 20449849
    [No Abstract]   [Full Text] [Related]  

  • 5. Gadolinium-binding helix-turn-helix peptides: DNA-dependent MRI contrast agents.
    Caravan P; Greenwood JM; Welch JT; Franklin SJ
    Chem Commun (Camb); 2003 Oct; (20):2574-5. PubMed ID: 14594287
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrast agents for MRI.
    Shokrollahi H
    Mater Sci Eng C Mater Biol Appl; 2013 Dec; 33(8):4485-97. PubMed ID: 24094150
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Detection and quantification of magnetically labeled cells by cellular MRI.
    Liu W; Frank JA
    Eur J Radiol; 2009 May; 70(2):258-64. PubMed ID: 18995978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metal-substituted protein MRI contrast agents engineered for enhanced relaxivity and ligand sensitivity.
    Lelyveld VS; Brustad E; Arnold FH; Jasanoff A
    J Am Chem Soc; 2011 Feb; 133(4):649-51. PubMed ID: 21171606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biomolecular MRI reporters: Evolution of new mechanisms.
    Mukherjee A; Davis HC; Ramesh P; Lu GJ; Shapiro MG
    Prog Nucl Magn Reson Spectrosc; 2017 Nov; 102-103():32-42. PubMed ID: 29157492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural principles for computational and de novo design of 4Fe-4S metalloproteins.
    Nanda V; Senn S; Pike DH; Rodriguez-Granillo A; Hansen WA; Khare SD; Noy D
    Biochim Biophys Acta; 2016 May; 1857(5):531-538. PubMed ID: 26449207
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The challenge of T1 contrast agents for high-magnetic field MRI.
    Helm L
    Chimia (Aarau); 2011; 65(9):696-8. PubMed ID: 22026182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Engineering and design in the bioelectrochemistry of metalloproteins.
    Gilardi G; Fantuzzi A; Sadeghi SJ
    Curr Opin Struct Biol; 2001 Aug; 11(4):491-9. PubMed ID: 11495744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superparamagnetic iron oxide nanoparticle probes for molecular imaging.
    Thorek DL; Chen AK; Czupryna J; Tsourkas A
    Ann Biomed Eng; 2006 Jan; 34(1):23-38. PubMed ID: 16496086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional MRI using molecular imaging agents.
    Jasanoff A
    Trends Neurosci; 2005 Mar; 28(3):120-6. PubMed ID: 15749164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bioinformatics of Metalloproteins and Metalloproteomes.
    Zhang Y; Zheng J
    Molecules; 2020 Jul; 25(15):. PubMed ID: 32722260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Chemical exchange saturation transfer contrast agents for magnetic resonance imaging.
    Sherry AD; Woods M
    Annu Rev Biomed Eng; 2008; 10():391-411. PubMed ID: 18647117
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gadonanotubes as new high-performance MRI contrast agents.
    Sitharaman B; Wilson LJ
    Int J Nanomedicine; 2006; 1(3):291-5. PubMed ID: 17717970
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation and quality test of superparamagnetic iron oxide labeled antisense oligodeoxynucleotide probe: a preliminary study.
    Wen M; Li B; Ouyang Y; Luo Y; Li S
    Ann Biomed Eng; 2009 Jun; 37(6):1240-50. PubMed ID: 19337837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Ferumoxytol vs. Gadolinium agents for contrast-enhanced MRI: Thoughts on evolving indications, risks, and benefits.
    Finn JP; Nguyen KL; Hu P
    J Magn Reson Imaging; 2017 Sep; 46(3):919-923. PubMed ID: 28160356
    [No Abstract]   [Full Text] [Related]  

  • 20. Nanotechnology and MRI contrast enhancement.
    Matson ML; Wilson LJ
    Future Med Chem; 2010 Mar; 2(3):491-502. PubMed ID: 21426177
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.